WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Morgan (Brown) Rhodes Logan
Associate
Technology Transactions
Boston
mrhodeslogan@wsgr.com

D617-598-7835

Download vCard
Open PDF

Morgan (Brown) Rhodes Logan is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where she is a member of the technology transactions group. Her practice focuses on the life sciences industry. She advises clients on various intellectual property and commercial transactions, including licensing, clinical trial agreements, material transfer agreements, and sponsored research agreements.

During law school, Morgan interned with Invest Detroit and the Mercury Fund.

Experience

Morgan (Brown) Rhodes Logan is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where she is a member of the technology transactions group. Her practice focuses on the life sciences industry. She advises clients on various intellectual property and commercial transactions, including licensing, clinical trial agreements, material transfer agreements, and sponsored research agreements.

During law school, Morgan interned with Invest Detroit and the Mercury Fund.

Education
  • J.D., University of Michigan Law School, 2018Competitor, Manfred Lachs Space Law Moot Court
  • B.A., Science & Society, Brown University, 2016Fellow, Brown Venture Fellowship
Associations and Memberships
  • Member, Massachusetts Black Lawyers Association
  • Member, Massachusetts Black Women Attorneys
Honors
  • Recognized among Massachusetts Lawyers Weekly's 2023 "Up & Coming Lawyers"
  • Honored by Senior Partners for Justice with the July 2022 Meg Connolly MVP Award
Admissions
  • State Bar of Massachusetts
Credentials
Education
  • J.D., University of Michigan Law School, 2018Competitor, Manfred Lachs Space Law Moot Court
  • B.A., Science & Society, Brown University, 2016Fellow, Brown Venture Fellowship
Associations and Memberships
  • Member, Massachusetts Black Lawyers Association
  • Member, Massachusetts Black Women Attorneys
Honors
  • Recognized among Massachusetts Lawyers Weekly's 2023 "Up & Coming Lawyers"
  • Honored by Senior Partners for Justice with the July 2022 Meg Connolly MVP Award
Admissions
  • State Bar of Massachusetts
Focus Areas
  • Biotech
  • Digital Health
  • Global Generics
  • Life Sciences
  • Medical Devices
  • Technology Transactions
Recent Insights
Client Highlights
Firm Advises Arcellx on $7.8 Billion Acquisition by Gilead
On February 23, 2026, Gilead Sciences announced that it has entered into a definitive agreement to acquire Arcellx, a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Proxima on $80 Million Seed Financing
On January 13, 2026, Proxima (formerly VantAI), the AI-native biotech company pioneering the next generation of AI-driven drug discovery for proximity therapeutics, announced an oversubscribed $80 million Seed financing.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.